GlaxoSmithKline (GSK) EPS US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EPS, rub | ? | 2.44 | 7.43 | 1.22 | 1.20 | 1.20 | 1.03 | ||
| Changes by years, y/y, % | -11% | +204% | -84% | -2% | +0% | -8.2% | |||
GlaxoSmithKline. EPS, rub
GlaxoSmithKline. EPS, changes, %
GlaxoSmithKline (GSK) EPS US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| EPS, rub | ? | 0.51 | 0.58 | 0.29 | -0.03 | -0.03 | 1.03 | |
| Changes by years, y/y, % | +40% | +44% | -28% | -104% | -104% | |||
| Changes by quarters, q/q, % | +496% | +12% | -50% | -110% | 0% | |||